| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |